KLRC1 and cancer: Natural killer group 2A (NKG2A) is an inhibitory checkpoint receptor that binds human leukocyte antigen-E (HLA-E) expressed on cancer cells, which could lead to the elimination of cancer cells by NKG2A-positive NK cells.